| Edwards Lifesciences is engaged in medical treatments for structural heart disease and critical care monitoring. Co. manufactures heart valve systems and repairs products used to replace or repair a patient's diseased or defective heart valve. Co.'s technologies is focused on the less invasive repair or replacement of the mitral and tricuspid valves of the heart. Co. is also engaged in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. Co.'s products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement, Surgical Structural Heart, Critical Care, and Transcatheter Mitral and Tricuspid Therapies. The Edwards Lifesciences YTD return is shown above.
The YTD Return on the Edwards Lifesciences YTD return page and across the coverage universe of our site,
is a measure of the total return for a given investment year-to-date for the current calendar year
(up to the end of prior trading session). Arguably, choosing the current calendar year for a measurement
period is on the one hand completely arbitrary, but on the other hand a year-to-date look can be extremely
useful in the context of our country's tax system which taxes gains and income on a calendar year basis.
Thus, researching Year-To-Date Returns is good practice for investors — whether Edwards Lifesciences YTD return or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's YTD return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the EW YTD return calculation (with any dividends reinvested as applicable), and to provide a
coverage universe of many stocks and ETFs to be able to compare YTD returns.